Group One Trading
KRSA

Group One Trading’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Group One Trading’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,557
Closed -$60K – 7194
2023
Q4 		$60K Hold
2,557
– – ﹤0.01% 4915
2023
Q3 		$60.9K Hold
2,557
– – ﹤0.01% 4900
2023
Q2 		$73.6K Buy
2,557
+2,423
+1,808% +$12.6K ﹤0.01% 4934
2023
Q1 		$8.15K Sell
134
-47
-26% -$593 ﹤0.01% 6050
2022
Q4 		$16.6K Sell
181
-26
-13% -$308 ﹤0.01% 5718
2022
Q3 		$25K Sell
207
-21
-9% -$361 ﹤0.01% 5917
2022
Q2 		$18K Sell
228
-33
-13% -$473 ﹤0.01% 6355
2022
Q1 		$41K Sell
261
-15
-5% -$361 ﹤0.01% 6246
2021
Q4 		$67K Sell
276
-602
-69% -$28.4K ﹤0.01% 6089
2021
Q3 		$377K Buy
878
+548
+166% +$35.9K ﹤0.01% 4506
2021
Q2 		$180K Buy
330
+327
+10,900% +$20.5K ﹤0.01% 5345
2021
Q1 		$1K Sell
3
-46
-94% -$3.46K ﹤0.01% 7448
2020
Q4 		$21K Buy
+49
New +$3.34K ﹤0.01% 5491

Other funds holding KRSA

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Group One Trading's KRSA Position: Q2 2026 in Review

Group One Trading held its Korsana Biosciences, Inc. Common Stock (KRSA) position steady in Q2 2026 at 27 shares worth $651. The position accounts for ﹤0.01% of the portfolio, ranked #7251.

Group One Trading first reported a position in KRSA in Q1 2020 and has held it in 26 quarters since. The position peaked at $104K in Q3 2021. 21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

  • Group One Trading held 27 shares of Korsana Biosciences, Inc. Common Stock worth $651 as of Q2 2026.
  • Group One Trading left its Korsana Biosciences, Inc. Common Stock share count unchanged in Q2 2026.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7251 holding.
  • Group One Trading first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2020 and has held it in 26 quarters since.
  • Group One Trading's Korsana Biosciences, Inc. Common Stock position peaked at $104K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.